Abstract: A golf club that positions a golfer to establish a desired viewpoint of a golf ball when preparing to strike the golf ball with the golf club. The golf club includes an elongated shaft, a grip provided adjacent to a proximate end of the shaft that the golfer grips to hold the golf club while striking the golf ball during a golf swing, and a club head coupled adjacent to a distal end of the shaft and including a face exposed at a surface of the head for contacting the golf ball during the golf swing. A visual indicator is provided to the club head, wherein the visual indicator is observable by the golfer to indicate that the golfer is positioned in at least one of a predetermined longitudinal direction relative to the club head and a predetermined lateral direction relative to the club head to afford the golfer the desired viewpoint of the golf ball before striking the golf ball.

Abstract: A golf club that positions a golfer to establish a desired viewpoint of a golf ball when preparing to strike the golf ball with the golf club. The golf club includes an elongated shaft, a grip provided adjacent to a proximate end of the shaft that the golfer grips to hold the golf club while striking the golf ball during a golf swing, and a club head coupled adjacent to a distal end of the shaft and including a face exposed at a surface of the head for contacting the golf ball during the golf swing. A visual indicator is provided to the club head, wherein the visual indicator is observable by the golfer to indicate that the golfer is positioned in at least one of a predetermined longitudinal direction relative to the club head and a predetermined lateral direction relative to the club head to afford the golfer the desired viewpoint of the golf ball before striking the golf ball.

Abstract: A golf club that positions a golfer to establish a desired viewpoint of a golf ball when preparing to strike the golf ball with the golf club. The golf club includes an elongated shaft, a grip provided adjacent to a proximate end of the shaft that the golfer grips to hold the golf club while striking the golf ball during a golf swing, and a club head coupled adjacent to a distal end of the shaft and including a face exposed at a surface of the head for contacting the golf ball during the golf swing. A visual indicator is provided to the club head, wherein the visual indicator is observable by the golfer to indicate that the golfer is positioned in at least one of a predetermined longitudinal direction relative to the club head and a predetermined lateral direction relative to the club head to afford the golfer the desired viewpoint of the golf ball before striking the golf ball.

Abstract: A golf club that positions a golfer to establish a desired viewpoint of a golf ball when preparing to strike the golf ball with the golf club. The golf club includes an elongated shaft, a grip provided adjacent to a proximate end of the shaft that the golfer grips to hold the golf club while striking the golf ball during a golf swing, and a club head coupled adjacent to a distal end of the shaft and including a face exposed at a surface of the head for contacting the golf ball during the golf swing. A visual indicator is provided to the club head, wherein the visual indicator is observable by the golfer to indicate that the golfer is positioned in at least one of a predetermined longitudinal direction relative to the club head and a predetermined lateral direction relative to the club head to afford the golfer the desired viewpoint of the golf ball before striking the golf ball.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the Formula ##STR1## that are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mannals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Abstract: Disclosed are novel substituted 3-aralkylimidazolines of the structure. ##STR1## processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy in particular as dopamine-.beta.-hydroxylase inhibitors.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the Formula: ##STR1## which are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Abstract: Disclosed are novel substituted 3-aralkyl-2-mercaptopyridines of the structure: ##STR1## processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy in particular as dopamine-.beta.-hydroxylase inhibitors.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the Formula: ##STR1## which are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Abstract: Compounds having the formula: ##STR1## which are ester prodrugs of potent dopamine-.beta.-hydroxylase inhibitors and thus are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmeceutical compositions including these compounds, and methods of using these compounds to inhibit dopamine-.beta.-hydroxylase activity in mammals.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the Formula: ##STR1## which are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Abstract: Potent dopamine-.beta.-hydroxylase inhibitors having the formula: ##STR1## which are useful to inhibit dopamine-.beta.-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-.beta.-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.

Abstract: The compounds of this invention are substituted benzofurans and benzothiophenes having pharmacological activity. In particular, these compounds have coronary vasodilator activity and are useful in the treatment of angina pectoris.

Abstract: The compounds of this invention are substituted benzofurans and benzothiophenes having pharmacological activity. In particular, these compounds have coronary vasodilator activity and are useful in the treatment of angina pectoris.

Abstract: .alpha.-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylbenzyl alcohols having .beta.-adrenergic stimulant activity, particularly as selected bronchodilators, are prepared from 4-hydroxyphenones by conversion to a 3-alkylsulfonylmethylphenone, bromination of these phenones and treatment of the resulting .alpha.-bromo derivatives with an N-benzyl secondary amine, followed by catalytic hydrogenation to remove the benzyl groups and reduce the ketone moiety.

Abstract: 4-Hydroxy-.alpha.-[(3,4-methylenedioxyphenyl)isopropylaminomethyl]-3-(methy lsulfonylmethyl)benzyl alcohol having .beta.-adrenergic stimulant activity, particularly as a selective bronchodilator, is prepared from 4-hydroxyacetophenone by conversion to 3-methylsulfonylmethylacetophenone, bromination and conversion of this phenone to the phenylglyoxal and treatment of the resulting glyoxal derivative with 3,4-methylenedioxyphenylisopropylamine followed by simultaneous reduction of the imine and ketone moieties and catalytic hydrogenation to remove the benzyl group.

Abstract: .alpha.-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylbenzyl alcohols having .beta.-adrenergic stimulant activity, particularly as selected bronchodilators, are prepared from 4-hydroxyphenones by conversion to a 3-alkylsulfonylmethylphenone, bromination of these phenones and treatment of the resulting .alpha.-bromo derivatives with an N-benzyl secondary amine, followed by catalytic hydrogenation to remove the benzyl groups and reduce the ketone moiety.